Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Sep 11-17;364(9438):963-9.
doi: 10.1016/S0140-6736(04)17020-7.

MMR Vaccination and Pervasive Developmental Disorders: A Case-Control Study

Affiliations

MMR Vaccination and Pervasive Developmental Disorders: A Case-Control Study

Liam Smeeth et al. Lancet. .

Abstract

Background: Concern that measles-mumps-rubella (MMR) vaccination might cause autism has led to a fall in vaccine coverage. We investigated whether MMR vaccination is associated with an increased risk of autism or other pervasive developmental disorders.

Methods: We did a matched case-control study using the UK General Practice Research Database. Cases were people born in 1973 or later who had first recorded diagnosis of pervasive developmental disorder while registered with a contributing general practice between 1987 and 2001. Controls were matched on age, sex, and general practice.

Findings: 1294 cases and 4469 controls were included. 1010 cases (78.1%) had MMR vaccination recorded before diagnosis, compared with 3671 controls (82.1%) before the age at which their matched case was diagnosed. After adjustment for age at joining the database, the odds ratio for association between MMR and pervasive developmental disorder was 0.86 (95% CI 0.68-1.09). Findings were similar when restricted to children with a diagnosis of autism, to those vaccinated with MMR before the third birthday, or to the period before media coverage of the hypothesis linking MMR with autism.

Interpretation: Our findings suggest that MMR vaccination is not associated with an increased risk of pervasive developmental disorders.

Similar articles

See all similar articles

Cited by 36 articles

See all "Cited by" articles

Publication types

Substances

LinkOut - more resources

Feedback